Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

被引：0
|
作者：
Antonio Bianchi
Ferdinando Valentini
Raffaella Iuorio
Maurizio Poggi
Roberto Baldelli
Marina Passeri
Antonella Giampietro
Linda Tartaglione
Sabrina Chiloiro
Marialuisa Appetecchia
Patrizia Gargiulo
Andrea Fabbri
Vincenzo Toscano
Alfredo Pontecorvi
Laura De Marinis
机构：
[1] Catholic University,Department of Endocrinology
[2] School of Medicine,Endocrinology Section
[3] San Camillo-Forlanini Hospital,Endocrinology Section
[4] University “La Sapienza”,Endocrinology Section
[5] St. Andrea Hospital,Endocrinology Unit
[6] University “La Sapienza”,Endocrinology Unit
[7] 2nd Faculty,undefined
[8] Regina Elena Cancer Institute – IFO,undefined
[9] St. Eugenio and CTO Andrea Alesini Hospital,undefined
[10] University of Tor Vergata,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 32卷
关键词：
Adenoma; Sleep Apnea; Acromegaly; Standard Deviation Score; Lanreotide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 11 条
  • [1] Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience
    Lv, Liang
    Hu, Yu
    Zhou, Peizhi
    Zhang, Shizhen
    Yin, Senlin
    Zhang, Nannan
    Jiang, Shu
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 167 : 24 - 30
  • [2] Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute
    Shen, Shih-Chieh
    Shen, Chiung-Chyi
    Pu, Ta-Wei
    Cheng, Wen-Yu
    WORLD NEUROSURGERY, 2019, 126 : E41 - E47
  • [3] Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs
    Matrone, C
    Pivonello, R
    Colao, A
    Cappabianca, P
    Cavallo, LM
    De Caro, MLD
    Taylor, JE
    Culler, MD
    Lombardi, G
    Di Renzo, GF
    Annunziato, L
    NEUROENDOCRINOLOGY, 2004, 79 (03) : 142 - 148
  • [4] Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
    Gurel, Michelle H.
    Han, Yi
    Stevens, Andrea L.
    Furtado, Aaron
    Cox, David
    BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
  • [5] Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
    Michelle H. Gurel
    Yi Han
    Andrea L. Stevens
    Aaron Furtado
    David Cox
    BMC Pharmacology and Toxicology, 18
  • [6] TREATMENT OF INVASIVE GROWTH-HORMONE PITUITARY-ADENOMAS WITH LONG-ACTING SOMATOSTATIN ANALOG SMS-201-995 BEFORE TRANSSPHENOIDAL SURGERY
    LUCASMORANTE, T
    GARCIAURIA, J
    ESTRADA, J
    SAUCEDO, G
    CABELLO, A
    ALCANIZ, J
    BARCELO, B
    JOURNAL OF NEUROSURGERY, 1994, 81 (01) : 10 - 14
  • [7] EFFECT OF A LONG-ACTING SOMATOSTATIN ANALOG (SMS 201-995) ON A GROWTH-HORMONE AND THYROID STIMULATING HORMONE-PRODUCING PITUITARY-TUMOR
    HIRASAWA, R
    HASHIMOTO, K
    MAKINO, S
    SUEMARU, S
    TAKAO, T
    OTA, Z
    HOSHIDA, Y
    YOSHINO, T
    AKAGI, T
    ACTA MEDICA OKAYAMA, 1991, 45 (02) : 107 - 115
  • [8] Long-term Changes in Serum IGF-1 Levels After Successful Surgical Treatment of Growth Hormone-Secreting Pituitary Adenoma
    Shin, Mi-Seon
    Yu, Ji Hee
    Choi, Jong Han
    Jung, Chang Hee
    Hwang, Jenie Yoonoo
    Cho, Young Hyun
    Kim, Chang Jin
    Kim, Min-Seon
    NEUROSURGERY, 2013, 73 (03) : 473 - 479
  • [9] Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
    Brooke Harrow
    Francis Fagnani
    Camille Nevoret
    Xuan-Mai Truong-Thanh
    Marie de Zélicourt
    Louis de Mestier
    Advances in Therapy, 2022, 39 : 1754 - 1771
  • [10] Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
    Harrow, Brooke
    Fagnani, Francis
    Nevoret, Camille
    Truong-Thanh, Xuan-Mai
    de Zelicourt, Marie
    de Mestier, Louis
    ADVANCES IN THERAPY, 2022, 39 (04) : 1754 - 1771
12